Burkitt Lymphoma, Beyond Discoveries
Guest edited by: Dr Sam Mbulaiteye
Burkitt Lymphoma (BL) is an aggressive non-Hodgkin lymphoma (NHL) that was first described by Dennis Burkitt in 1958 in Ugandan children. Since then, numerous breakthroughs, including the discovery of the Epstein-Barr virus (EBV), and its links to the disease, have been made. The most important of these discoveries has been the demonstration of curability of lymphoma which has re-invigorated efforts to use chemotherapy to treat cancer and helped establish some of the key principles of chemotherapy, affecting cancers more broadly, including combined modality therapy, attention to tumor lysis syndrome, and treatment of sanctuary sites. In spite of this, fundamental questions about BL remain unanswered.
This collection of articles has not been sponsored and articles have undergone the journal's standard peer-review process. The Guest Editor declares no competing interest.
View all collections published in Infectious Agents and Cancer.